Vurolenatide (9 Meters Biopharma)

N/A

Report date: 2024/11/23 20:00:08

Base Information

Drug NameVurolenatide (9 Meters Biopharma)
Drug Alias Namerecombinant fusion protein comprising exenatide and XTENNB-1001NM-002
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsShort Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAmunix Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies9 Meters Biopharma IncNaia Ltd
Active IndicationsN/A
Inactive IndicationsShort Bowel Syndrome

Other Information

ATC CodeN/A
Related LinksN/A